Precise Aβ clearance and antioxidant therapy in Alzheimer’s disease via photoacoustic imaging-guided palladium hydride nanosheet-mediated photothermal treatment.
Lujie Yu, Mingxin Zhao, Wenjing Zhang, Zhigan Lv, Keqi Zhao, Huailiang Li, Yunjie Qi, Xin Peng, Ziliang Zheng, Weiwei Zhang · BMC neuroscience · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, the excellent small-sized therapeutic nanoparticles the researchers designed and synthesised can easily cross the blood-brain barrier to the site of inflammation in the brain and achieve in situ release of hydrogen to reduce neuroinflammation. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. The excellent small-sized therapeutic nanoparticles the researchers designed and synthesised can easily cross the blood-brain barrier to the site of inflammation in the brain and achieve in situ release of hydrogen to reduce neuroinflammation.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
Pd(acac)2 (50 mg), PVP (30 mg), and NaBr (52.2 mg) were dissolved in a mixture of DMF (10 mL) and H₂O (2 mL). Pd nanoparticles were poured into a 20 mL vial, and the hydrogen generated by the hydrogen generator was blown into the Pd nanoparticle solution. After 15 min, hydrogenation was stopped, and the vial containing the PdH nanoparticles was stored in the dark for later use. The excellent small-sized therapeutic nanoparticles the researchers designed and synthesised can easily cross the blood-brain barrier to the site of inflammation in the brain and achieve in situ release of hydrogen to reduce neuroinflammation.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.